# MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
Canonical URL: https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference
Ticker: MDXG
Company: MiMedx
Source: MiMedx
Published: 2026-06-25 13:46 EST
Original Source URL: https://mimedx.gcs-web.com
## Summary

MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23 rd Annual Institutional Investor Conference on Thursday, May 28, 2026 in Minneapolis, MN.

## Article Body
MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23 rd Annual Institutional Investor Conference on Thursday, May 28, 2026 in Minneapolis, MN.
## Recent Company News
- 2026-06-25 13:46 EST — [MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference](https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference) — Source: MiMedx
- 2026-06-25 13:46 EST — [MIMEDX Announces Launch of G4Derm® Plus](https://biopharmsignal.com/news/MDXG/mimedx-announces-launch-of-g4dermr-plus) — Source: MiMedx
- 2026-06-25 13:46 EST — [MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®](https://biopharmsignal.com/news/MDXG/mimedx-celebrates-15-year-anniversary-of-epifixr-and-amniofixr) — Source: MiMedx
- 2026-06-25 13:46 EST — [MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products](https://biopharmsignal.com/news/MDXG/mimedx-enters-into-exclusive-distribution-agreement-with-summit-products-group-for-multiple-innovative-surgical-and-wound-products) — Source: MiMedx
- 2026-06-25 13:46 EST — [MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25](https://biopharmsignal.com/news/MDXG/mimedx-to-host-fourth-quarter-and-full-year-2025-operating-and-financial-results-conference-call-on-february-25) — Source: MiMedx
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)